Fernanda Costas Casal de Faria

This researcher studies liposarcoma, a rare type of soft-tissue cancer that arises from fat cells, focusing on how tumor cells evade the immune system and on finding new drug targets and biomarkers, such as the protein TRAP1 and DNA carried in extracellular vesicles (tiny particles cells release into blood). Much of the recent work involves building 3D lab models (like organoids) to study these tumors and developing liquid biopsy tests that could help detect or monitor the disease from a blood sample. Earlier work in the researcher's record also touched on leukemia biology, including drug transporter proteins and genetic markers of leukemia transformation.

Publication output was low and sporadic from 2017-2021 but has grown noticeably since 2022, peaking in 2024, suggesting an increasingly active recent research program.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026